Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole duration in extended adjuvant therapy for endocrine-sensitive early breast cancer
2006-003958-16Phase 3Active
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole in breast cancer (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Disease-free survival. Started Jul 2007; status: active.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-003958-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003958-16.